Sirius XM Holdings Inc. (NASDAQ:SIRI) caters to the Services space. It has a net profit margin of 11.60% and weekly performance is -0.50%. On the last day of trading company shares ended up at $3.99. Sirius XM Holdings Inc. (NASDAQ:SIRI) distance from 50-day simple moving average (SMA50) is -12.50%.
On 9 December, Sirius XM Holdings Inc. (NASDAQ:SIRI) has unveiled a slate of extensive programming to celebrate FRANK SINATRA’s 100th birthday on his exclusive channel, SIRIUSLY SINATRA. The schedule will include a new special hosted by NANCY SINATRA including some of her personal favorites; shows hosted by FRANK SINATRA, JR.
Clovis Oncology, Inc. (NASDAQ:CLVS) ended the last trading day at $32.80. Company weekly volatility is calculated as 6.49% and price to cash ratio as 2.07. Clovis Oncology, Inc. (NASDAQ:CLVS) showed a weekly performance of 2.66%.
Clovis Oncology, Inc. (NASDAQ:CLVS) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for Clovis’ New Drug Application (NDA) for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016.
On 18 December, Whitestone REIT (NYSE:WSR) shares advanced 0.67% and was closed at $12.10. WSR EPS growth in last 5 year was -11.70%. Whitestone REIT (NYSE:WSR) year to date (YTD) performance is -12.93%.
Whitestone REIT (NYSE:WSR) announced that its Board of Trustees has declared a quarterly cash dividend for the 2016 first quarter of 28.5 cents per share on the Company’s common stock and Operating Partnership units. The first quarter dividend will be paid in three installments of 9.5 cents each in January, February and March. T
Swift Transportation Company (NYSE:SWFT) shares decreased -6.77% in last trading session and ended the day at $13.21. SWFT Gross Margin is 52.00% and its has a return on assets of 6.30%. Swift Transportation Company (NYSE:SWFT) quarterly performance is -31.20%.
Longbow Research downgraded shares of Swift Transportation Company (NYSE:SWFT) from a buy rating to a neutral rating in a report published on Friday, The Fly reports.
Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) caters to the Healthcare space. Its weekly performance is -7.02%. On the last day of trading company shares ended up at $1.06. Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) distance from 50-day simple moving average (SMA50) is -1.05%.
Skystar Bio Pharmaceutical Company (NASDAQ:SKBI) announced that on December 17, 2015, Skystar Bio-Pharmaceutical Company (the “Company”) received notification from The Nasdaq Stock Market (“Nasdaq”) informing the Company that a Nasdaq hearing panel had decided to delist the Company’s shares from Nasdaq and that the Company’s shares would be suspended from trading on Nasdaq at the open of business on December 21, 2015.
Leave a Reply